Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03908320 · ClinicalTrials.gov registry record · NA

Menstrual Phase and Smoking Cessation at a State Quitline

A NA study, sponsored by University of Arizona.

Completed
Registry status
NA
Development phase
119
Enrollment target

NCT03908320 is a NA study that has completed, run by University of Arizona. The registered enrollment target is 119 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03908320, a NA study, has completed, sponsored by University of Arizona.

COMPLETED
Registry status
NA
Development phase
119 participants
Enrollment target

Study Summary

Quitlines are efficient and cost-effective treatments for smoking cessation, yet little research has explored how to personalize and optimize quitline services for women. The goal of this project is to explore the feasibility and preliminary efficacy of a quitline intervention that considers the menstrual cycle as compared to standard care for cessation. If funded, the results of this study will directly inform future research on quitline smoking cessation interventions for premenopausal women, including a full scale clinical trial.

Interventions

  • BEHAVIORAL Cessation Counseling
  • OTHER Menstrual Cycle Timing
  • DRUG NRT Patch

Trial Details

FieldValue
Enrollment Target 119 participants
Start Date 2019-01-15
Est. Completion 2020-09-30
Phase NA

Sponsor

University of Arizona

349 total trials

What the Registry Record Tells You About NCT03908320

The ClinicalTrials.gov registry entry for NCT03908320 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 119 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Arizona, which has 349 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which Cessation Counseling is the first listed.

NCT03908320 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03908320 about?

NCT03908320 is a clinical study titled "Menstrual Phase and Smoking Cessation at a State Quitline". Quitlines are efficient and cost-effective treatments for smoking cessation, yet little research has explored how to personalize and optimize quitline services for women. The goal of this project is to explore the feasibility and preliminary efficacy of a quitline intervention that considers the men...

What is the current status of trial NCT03908320?

This trial is currently completed. It is a NA study. The enrollment target is 119 participants. The study started on 2019-01-15. Estimated completion is 2020-09-30.

What interventions are being tested in trial NCT03908320?

The interventions under investigation include: Cessation Counseling (BEHAVIORAL), Menstrual Cycle Timing (OTHER), NRT Patch (DRUG).

Who is sponsoring clinical trial NCT03908320?

This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.